Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 6 days agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 4 days agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days ago"That said, Novavax's vaccine has demonstrated strong protection to date, and we will be interested...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines PR Newswire GAITHERSBURG ...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 6 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 4 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...